Karl‐Ove Söderström
Impact in
- Reproductive Medicine top 5%
- Sperm and Testicular Function
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Sperm and Testicular Function 11
- Co-authors
- Martti ParvinenMatti LaatoTero VahlbergHeikki JoensuuJyrki SuominenPeter J. BoströmVesa AaltonenAri Rinne
- Journals
- Cancer (5 papers)Hereditas (3 papers)International Journal of Cancer (3 papers)International Journal of Gynecological Pathology (2 papers)BMC Cancer (2 papers)
- Partner nations
- FinlandNorwayUnited States
In The Last Decade
Karl‐Ove Söderström
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Reproductive Medicine 146
- Cancer Research 250
- Rheumatology 179
- Immunology and Allergy 64
- Oncology 260
Countries citing papers authored by Karl‐Ove Söderström
This map shows the geographic impact of Karl‐Ove Söderström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl‐Ove Söderström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl‐Ove Söderström more than expected).
Fields of papers citing papers by Karl‐Ove Söderström
This network shows the impact of papers produced by Karl‐Ove Söderström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl‐Ove Söderström. The network helps show where Karl‐Ove Söderström may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Karl‐Ove Söderström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 46 | |
| 2 | 2011 | 76 | |
| 3 | 2009 | 0 | |
| 4 | 2009 | 1 | |
| 5 | 2008 | 0 | |
| 6 | 2006 | 15 | |
| 7 | Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. | 2003 | 92 |
| 8 | 2003 | 30 | |
| 9 | 2002 | 14 | |
| 10 | 2001 | 33 | |
| 11 | 1999 | 39 | |
| 12 | 1998 | 24 | |
| 13 | 1995 | 59 | |
| 14 | 1995 | 34 | |
| 15 | 1992 | 70 | |
| 16 | 1991 | 2 | |
| 17 | 1987 | 37 | |
| 18 | 1987 | 20 | |
| 19 | 1986 | 41 | |
| 20 | 1983 | 25 |
About Karl‐Ove Söderström
Karl‐Ove Söderström is a scholar working on Reproductive Medicine, Structural Biology, Cancer Research, Rheumatology and Genetics, having authored 51 papers that have together received 1.3k indexed citations. Recurring topics across this work include Sperm and Testicular Function (11 papers), Glycosylation and Glycoproteins Research (6 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (6 papers), Protease and Inhibitor Mechanisms (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Medical Imaging Techniques and Applications (3 papers), Cancer Genomics and Diagnostics (3 papers) and Testicular diseases and treatments (3 papers). The work is most often cited by research in Reproductive Medicine (146 citations), Cancer Research (250 citations), Rheumatology (179 citations), Immunology and Allergy (64 citations) and Oncology (260 citations). Karl‐Ove Söderström has collaborated with scholars based in Finland, Norway and United States. Frequent co-authors include Martti Parvinen, Matti Laato, Tero Vahlberg, Heikki Joensuu, Jyrki Suominen, Peter J. Boström, Vesa Aaltonen, Ari Rinne, Pekka Klemi and T Hirvonen. Their work appears in journals such as Cancer, Hereditas, International Journal of Cancer, International Journal of Gynecological Pathology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.